Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | CRHBP | P24387 | 1/20 | 0.30 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.30 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.30 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18069152 | 0.91 | MAPT (0.40) | MEN1MAPTKMT2AL3MBTL1POLB | |
| SCHEMBL18069157 | 0.88 | MAPT (0.38) | MEN1MAPTKMT2AL3MBTL1POLB | |
| SCHEMBL18069151 | 0.87 | MAPT (0.38) | MEN1MAPTKMT2AL3MBTL1POLB | |
| SCHEMBL18069154 | 0.86 | MEN1 (0.36) | MEN1MAPTKMT2AL3MBTL1POLB | |
| SCHEMBL18069176 | 0.86 | KMT2A (0.41) | MEN1MAPTKMT2AL3MBTL1POLB | |
| SCHEMBL18071769 | 0.86 | ELANE (0.38) | MEN1MAPTKMT2AL3MBTL1POLB | |
| SCHEMBL18071767 | 0.86 | MEN1 (0.38) | MEN1MAPTKMT2AL3MBTL1POLB | |
| SCHEMBL18174463 | 0.85 | MEN1 (0.37) | MEN1MAPTKMT2AL3MBTL1POLB | |
| SCHEMBL18069167 | 0.84 | TDP1 (0.39) | MEN1MAPTKMT2AL3MBTL1POLB | |
| SCHEMBL18069163 | 0.84 | MEN1 (0.39) | MEN1MAPTKMT2AL3MBTL1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160266487-A1 | SULFONIC ACID DERIVATIVE COMPOUNDS AS PHOTOACID GENERATORS IN RESIST APPLICATIONS | HERAEUS EPURIO LLC | 2016-09-15 | — | — | US | disclosed |
| US-20160266487-A1 | SULFONIC ACID DERIVATIVE COMPOUNDS AS PHOTOACID GENERATORS IN RESIST APPLICATIONS | HERAEUS EPURIO LLC | 2016-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160266487-A1 | SULFONIC ACID DERIVATIVE COMPOUNDS AS PHOTOACID GENERATORS IN RESIST APPLICATIONS | ALAD, MPST, ASIC1 | MEN1 1317/4885MAPT 3437/4885KMT2A 1020/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.